Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- manufacturers
- Debio-0123
-
- $96.00
-
2026-07-27
- CAS:2243882-74-6
- Purity: 99.75%
- Supply Ability: 10g
|
| | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- Basic information |
| Product Name: | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- | | Synonyms: | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]-;WEE1-IN-5;3-(2,6-Dichlorophenyl)-1-methyl-7-((3-methyl-4-(1-methylpiperidin-4-yl)phenyl)amino)-2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-one , WEE1-IN-5;3-(2,6-Dichlorophenyl)-1-methyl-7-((3-methyl-4-(1-methylpiperidin-4-yl)phenyl)amino)-2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-one;Debio-0123, 10 mM in DMSO;3-(2,6-dichlorophenyl)-1-methyl-7-{[3-methyl-4-(1-methylpiperidin-4-yl)phenyl]amino}-2H-[1,3]diazino[4,5-d]pyrimidin-4-one - [AC80905];3-(2,6-Dichlorophenyl)-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidyl)phenyl]amino]-2,3-dihydropyrimido[4,5-d]pyrimidin-4(1H)-one;Debio-0123 | | CAS: | 2243882-74-6 | | MF: | C26H28Cl2N6O | | MW: | 511.45 | | EINECS: | | | Product Categories: | | | Mol File: | 2243882-74-6.mol | ![Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- Structure](CAS/20200611/GIF/2243882-74-6.gif) |
| | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- Chemical Properties |
| Boiling point | 684.4±65.0 °C(Predicted) | | density | 1.331±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 125 mg/mL (244.40 mM; Need ultrasonic) | | form | Solid | | pka | 8.97±0.20(Predicted) | | color | White to off-white | | InChIKey | VWHNEYAANMETIA-UHFFFAOYSA-N | | SMILES | C1N(C2=C(Cl)C=CC=C2Cl)C(=O)C2=CN=C(NC3=CC=C(C4CCN(C)CC4)C(C)=C3)N=C2N1C |
| | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- Usage And Synthesis |
| Uses | WEE1-IN-5 is a potent WEE1 inhibitor with an IC50 value of 0.8 nM. WEE1-IN-5 inhibits phospho-CDC2. WEE1-IN-5 abrogates the G2 check point, increasing sensitivity to DNA damaging agents in cancer cells. WEE1-IN-5 can be used for researching anticancer[1]. | | in vivo | WEE1-IN-5 (5mg/kg for PO; 1 mg/kg for IV; single dosage) exhibits a CL of 14 mL/min/kg, an AUCint 1324 h·ng/mL and bioavailability of 35% in SD rats[1]. | | References | [1] H. Gelderblom, et al. 601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours. Ann Oncol. 2020 Sep; 31: S501-S502. |
| | Pyrimido[4,5-d]pyrimidin-4(1H)-one, 3-(2,6-dichlorophenyl)-2,3-dihydro-1-methyl-7-[[3-methyl-4-(1-methyl-4-piperidinyl)phenyl]amino]- Preparation Products And Raw materials |
|